Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Palvella Therapeutics, Inc. (PVLA) had Return on Tangible Equity of -19.82% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-9.47M |
|
-- |
|
-- |
|
$9.25M |
|
$-9.25M |
|
$-0.22M |
|
$-9.47M |
|
$-9.47M |
|
$-9.47M |
|
$-9.47M |
|
$-9.47M |
|
$-9.47M |
|
$-9.25M |
|
$-9.25M |
|
11.05M |
|
11.05M |
|
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$73.75M |
|
-- |
|
-- |
|
$73.75M |
|
$9.62M |
|
-- |
|
$16.35M |
|
$25.97M |
|
$47.78M |
|
$47.78M |
|
$47.78M |
|
11.06M |
|
| Cash Flow Statement Financials | |
$-12.20M |
|
-- |
|
$-0.85M |
|
$83.60M |
|
$70.43M |
|
$-13.17M |
|
$2.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.82% |
|
|
Return on Tangible Equity |
-19.82% |
-12.84% |
|
-19.82% |
|
$4.32 |
|
$-1.10 |
|
$-1.10 |
|